CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2020		Sep. 30, 2020		Jun. 30, 2020		Mar. 31, 2020		Dec. 31, 2019		Sep. 30, 2019		Jun. 30, 2019		Mar. 31, 2019		Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenues:
Premiums																	$ 4,110	$ 4,037	$ 3,994
Net investment income																	3,260	3,220	3,121
Net investment gains (losses)																	558	50	(9)
Policy fees and other income																	730	789	795
Total revenues	$ 2,263	[1]	$ 2,420	[1]	$ 2,138	[1]	$ 1,837	[1]	$ 2,038		$ 2,020		$ 1,994		$ 2,044		8,658	8,096	7,901
Benefits and expenses:
Benefits and other changes in policy reserves																	5,391	5,163	5,606
Interest credited																	549	577	611
Acquisition and operating expenses, net of deferrals																	988	962	943
Amortization of deferred acquisition costs and intangibles																	492	441	348
Goodwill impairment																	5	0	0
Interest expense																	202	239	256
Total benefits and expenses	1,883	[2]	1,835	[2]	1,990	[2]	1,919	[2]	1,957	[3]	1,848	[3]	1,770	[3]	1,807	[3]	7,627	7,382	7,764
Income from continuing operations before income taxes																	1,031	714	137
Provision for income taxes																	270	195	70
Income (loss) from continuing operations	296	[1],[2],[4]	435	[1],[2],[4]	102	[1],[2],[4]	(72)	[1],[2],[4]	55	[5]	138	[5]	158	[5]	168	[5]	761	519	67
Income (loss) from discontinued operations, net of taxes	(30)	[6]	1	[6]	(520)	[6]	0	[6]	(31)	[7]	(80)	[7]	60	[7]	62	[7]	(549)	11	230
Net income	266	[1],[2],[4],[6]	436	[1],[2],[4],[6]	(418)	[1],[2],[4],[6]	(72)	[1],[2],[4],[6]	24	[5],[7]	58	[5],[7]	218	[5],[7]	230	[5],[7]	212	530	297
Less: net income from continuing operations attributable to noncontrolling interests	(1)		18		23		(6)		19		10		15		20		34	64	70
Less: net income from discontinued operations attributable to noncontrolling interests	0		0		0		0		22		30		35		36		0	123	108
Net income available to Genworth Financial, Inc.'s common stockholders	267		418		(441)		(66)		(17)		18		168		174		178	343	119
Net income (loss) available to Genworth Financial, Inc.'s common stockholders:
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders	297		417		79		(66)		36		128		143		148		727	455	(3)
Income (loss) from discontinued operations available to Genworth Financial, Inc.'s common stockholders	(30)		1		(520)		0		(53)		(110)		25		26		(549)	(112)	122
Net income available to Genworth Financial, Inc.'s common stockholders	$ 267		$ 418		$ (441)		$ (66)		$ (17)		$ 18		$ 168		$ 174		$ 178	$ 343	$ 119
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per share:
Basic	$ 0.59		$ 0.83		$ 0.16		$ (0.13)		$ 0.07		$ 0.25		$ 0.29		$ 0.29		$ 1.44	$ 0.90	$ (0.01)
Diluted	0.58		0.82		0.15		(0.13)		0.07		0.25		0.28		0.29		1.42	0.89	(0.01)
Net income available to Genworth Financial, Inc.'s common stockholders per share:
Basic	0.53		0.83		(0.87)		(0.13)		(0.03)		0.04		0.33		0.35		0.35	0.68	0.24
Diluted	$ 0.52		$ 0.82		$ (0.86)		$ (0.13)		$ (0.03)		$ 0.04		$ 0.33		$ 0.34		$ 0.35	$ 0.67	$ 0.24
Weighted-average common shares outstanding:
Basic	505.6		505.6		505.4		504.3		503.5		503.5		503.4		501.2		505.2	502.9	500.4
Diluted	512.5	[8]	511.5	[8]	512.5	[8]	504.3	[8]	510.4		511.2		508.7		508.6		511.6	509.7	500.4

[1] In the fourth quarter of 2020, we recorded lower net investment gains as compared to the third quarter of 2020. The higher net investment gains recorded in the third quarter of 2020 related to the sale of available-for-sale fixed maturity securities of $330 million driven primarily from the sale of U.S. government securities due to portfolio rebalancing and asset exposure management as a result of the prolonged low interest rate environment. This decrease to total revenues was partially offset by higher net investment income recorded in the fourth quarter of 2020 largely driven by bond calls and mortgage loan repayments of $40 million and limited partnerships of $38 million.

[2] Given our assumption that COVID-19 has temporarily decreased the number of new claims submitted, our long-term care insurance business strengthened IBNR reserves in the fourth quarter of 2020 by $47 million. Additionally, our long-term care insurance business recorded a $91 million increase to claim reserves reflecting our assumption that COVID-19 accelerated mortality experience on the most vulnerable claimants, leaving the remaining claim population less likely to terminate compared to the pre-pandemic average population. Our U.S. mortgage insurance business recorded an unfavorable reserve adjustment of $37 million primarily due to slowing cure emergence patterns impacting the frequency of claim. Our Australia mortgage insurance business strengthened its loss reserves by $88 million, including its IBNR reserves, due to a refinement in methodology to better align with historical delinquency behavior, as well as to reflect delayed impacts from higher expected delinquencies and the pressured economic conditions caused by COVID-19. Our life insurance business completed its annual review of assumptions in the fourth quarter of 2020. This review resulted in lower total benefits and expenses of $82 million from a net favorable unlocking in our term universal and universal life insurance products largely attributable to a model refinement in our term universal life insurance product related to persistency and grace period timing and lower projected cost of insurance assessments on our universal life insurance products. In addition, we recorded a DAC impairment of $63 million in our universal life insurance products due principally to lower future estimated gross profits.

[3] Our life insurance business completed its annual review of assumptions in the fourth quarter of 2019, which resulted in higher total benefits and expenses of $145 million from an unfavorable unlocking in our universal and term universal life insurance products driven mostly by the lower interest rate environment.

[4] In the fourth quarter of 2020, our long-term care insurance business strengthened its reserves by $109 million after-tax. Our U.S. mortgage insurance and Australia mortgage insurance businesses strengthened their loss reserves by $29 million and $62 million, respectively, after-tax. Our life insurance business recorded a $60 million net favorable unlocking, net of taxes, related to its annual review of assumptions. This favorable unlocking in our life insurance business was partially offset by a DAC impairment of $50 million, net of taxes, as a result of recoverability testing. For all of the aforementioned transactions, see above under superscript (2) for additional details.

[5] In the fourth quarter of 2019, our life insurance business recorded a $107 million unfavorable unlocking, net of taxes, related to its annual review of assumptions in our universal and term universal life insurance products, as described above. This unfavorable unlocking in our life insurance business was partially offset by a favorable update of $11 million, net of taxes, in our U.S. mortgage insurance business in connection with a review of its single premium earnings pattern and from a favorable reserve adjustment of $10 million, net of taxes.

[6] In the fourth quarter of 2020, we recorded a loss from discontinued operations, net of taxes, of $30 million principally attributed to foreign currency remeasurement losses of $26 million, unfavorable tax charges of $17 million and other expenses of $8 million, mostly consisting of interest expense attributable to the promissory note owed to AXA. These losses were partially offset by derivative hedge gains of $21 million associated with foreign currency forward contracts entered into to mitigate our exposure to the installment payments to be made in British Pounds in 2022. See note 23 for additional details on discontinued operations.

[7] In the fourth quarter of 2019, we recorded an after-tax loss of approximately $110 million principally in connection with pending litigation involving our former lifestyle protection insurance business. See note 20 for additional information related to asserted claims regarding the sale of our lifestyle protection insurance business. We completed the sale of Genworth MI Canada Inc. (“Genworth Canada”) on December 12, 2019 and recorded an incremental gain of $43 million in the fourth quarter of 2019 predominantly related to a favorable tax position refinement. In addition, during the fourth quarter of 2019 through the sale closing date of December 12, 2019, we recorded $36 million of income from discontinued operations attributed to Genworth Canada.

[8] Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended March 31, 2020, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders for the three months ended March 31, 2020, dilutive potential weighted-average common shares outstanding would have been 509.7 million.